BioCentury
ARTICLE | Finance

Bargain shopping

Biotech winners, losers in 3Q17

October 6, 2017 11:52 PM UTC

With all companies valued over $1 billion increasing a median of at least 16.8% in 1H17, investors went bargain shopping in the $500-$999 million tier in 3Q17. The group outperformed all other market cap bands, aided by outstanding after-market performance from a trio of new IPOs.

Companies valued over $10 billion increased a median of just 1.7% last quarter, though gainers outpaced decliners 14 to nine and $139 billion of equity value was created (see “Results by Market Cap”)...